[
    {
        "question": "First line treatment of T315I mutation in CML management is?",
        "exp": "T315I mutation is a mutation in the critical BCR-ABL kinase in the ATP-binding pocket This prevents imatinib binding and hence leads to resistance to imatinib, nilotinib, bosutinib, and dasatinib. Only drug effective for T315I mutation CML = Ponatinib. Otherwise DOC CML= Imatinib. DOC for Imatinib resistant CML = Bosutinib DOC in case of failure of > 2 Tyrosine kinase inhibitor = OMACETAXINE",
        "cop": 3,
        "opa": "Bosutinib",
        "opb": "Tofacitinib",
        "opc": "Ponatinib",
        "opd": "Nilotinib",
        "subject_name": "Medicine",
        "topic_name": "CLL & CML",
        "id": "20442569-e3fd-409b-93f9-d92923cd6b15",
        "choice_type": "single"
    },
    {
        "question": "Nurse like cells are seen in?",
        "exp": "Nurse like cell are Tumor associated Macrophages | Produce cytokines | Provide nourishment to cancer cells | Clonal expansion of the immature B - Cell | Uncontrolled mitosis of immune incompetent B cell in CLL",
        "cop": 1,
        "opa": "Chronic Lymphoblatic Leukemia",
        "opb": "Hodgkin Lymphoma",
        "opc": "Non Hodgkin Lymphoma",
        "opd": "Acute Lymphoblatic Leukemia",
        "subject_name": "Medicine",
        "topic_name": "CLL & CML",
        "id": "0f173190-b545-40b3-b1e0-5dfbad74069d",
        "choice_type": "single"
    },
    {
        "question": "Leading cause of death in CLL is?",
        "exp": "Infections are a leading cause death in patients with CLL Abnormalities in cellular and humoral immunity leading to the immune dysfunction patients are at risk for both typical and atypical infections. Most CLL therapies can increase infection risk. Hence prophylaxis for Pneumocystis pneumonia and viral infections is indicated for at least 6 months following therapy to allow recovery of functional T cells. Extra edge MC leukaemia in adults: CLL Binet Classification: for CLL Smudge cells seen in: CLL",
        "cop": 1,
        "opa": "Infections",
        "opb": "Bleeding",
        "opc": "Meningeal and ventricular extension",
        "opd": "DIC",
        "subject_name": "Medicine",
        "topic_name": "CLL & CML",
        "id": "e85ddc20-2e97-4186-922d-23e22092b455",
        "choice_type": "single"
    },
    {
        "question": "Vitamin B12 level in chronic myeloid leukemia is:",
        "exp": "Chronic Myelogenous leukaemia Increased levels of Vitamin B12 levels Uric acid levels Serum LDH levels Lysozyme Decreased levels of LAP( Leukocyte Alkaline Phosphatase )",
        "cop": 1,
        "opa": "Elevated",
        "opb": "Decreased (slightly)",
        "opc": "Normal",
        "opd": "Markedly decreased",
        "subject_name": "Medicine",
        "topic_name": "CLL & CML",
        "id": "ad66acd7-b526-47d8-9ee5-6c3be352ca78",
        "choice_type": "single"
    },
    {
        "question": "An 80 year old, asymptomatic man presents with a Total leucocyte count of 1 lakh, with 80% lymphocytes and 20% PMN. What is the most probable diagnosis?",
        "exp": "The above given clinical presentation points towards a diagnosis of CLL (Chronic Lymphocytic Leukemia) Its median age of presentation is 65 years with 53% male presentation. The diagnosis of typical CLL is made with B-cell lymphocytosis greater than 5000/uL & coexpression of CD19, CD5 on lymphocytes. PBF shows \"smudge\" or \"basket\" cells Warm autoimmune hemolytic anemia (IgG), Coombs test positive Cytogenetic studies reveal trisomy 12 CML presents with massive splenomegaly, elevated WBC, increase in both immature and mature granulocytes. At diagnosis, bone marrow cellularity is increased, with an increased myeloid-to-erythroid ratio. TB presents with symptoms while presentation of the given patient is asymptomatic",
        "cop": 3,
        "opa": "HIV",
        "opb": "CML",
        "opc": "CLL",
        "opd": "TB",
        "subject_name": "Medicine",
        "topic_name": "CLL & CML",
        "id": "716446a1-723f-4a2e-8269-142865d25a50",
        "choice_type": "single"
    },
    {
        "question": "BCL-2 inhibitor used in CLL is?",
        "exp": "BCL- 2 inhibitor used in CLL is Venetoclax. It works by promoting apoptosis. CLL - Most common Blood Cancer (leukemia) in Adult population. Rx- Chemoimmunotherapy + Monoclonal Antibody F C R Fludrabine Cyclophosphamide Rituximab P C R Pentostatin Cyclophosphamide Rituximab",
        "cop": 4,
        "opa": "Fludarabine",
        "opb": "Cladiribine",
        "opc": "Pentostatin",
        "opd": "Venetoclax",
        "subject_name": "Medicine",
        "topic_name": "CLL & CML",
        "id": "55fe2472-e227-49e8-ba1f-ad57908fb63b",
        "choice_type": "single"
    },
    {
        "question": "Richter transformation is conversion of?",
        "exp": "MC B cell NHL: DLBCL CLL/SLL (Small lymphocytic lymphoma) | Richter transformation DLBCL (Diffuse lager B cell Lymphoma) Clinical signs of Richter's transformation include rapid progression in lymphadenopathy and constitutional symptoms including fatigue, night sweats, fever, and weight loss. LDH is usually high. Therapy for DLBCL Richter's transformation usually involves combination chemoimmunotherapy.",
        "cop": 1,
        "opa": "CLL into DLBCL",
        "opb": "DLBCL into CLL",
        "opc": "SLL into CLL",
        "opd": "CLL into SLL",
        "subject_name": "Medicine",
        "topic_name": "CLL & CML",
        "id": "a877e4c0-6f8a-4dcf-87c4-1a4bace3aa0e",
        "choice_type": "single"
    },
    {
        "question": "Which has worst prognosis in CLL?",
        "exp": "13q deletion: Indolent course; good prognosis Trisomy 12: Intermediate prognosis 11q deletion: Poor prognosis 17p deletion: Poorest prognosis",
        "cop": 3,
        "opa": "11q Deletion",
        "opb": "12q Trisomy",
        "opc": "17p Deletion",
        "opd": "13q Deletion",
        "subject_name": "Medicine",
        "topic_name": "CLL & CML",
        "id": "53953ea2-8dff-47e9-874b-5164be2c3550",
        "choice_type": "single"
    },
    {
        "question": "Which of these is not a feature of C. M. L?",
        "exp": "Autoimmune hemolytic anemia is a feature of CLL Features of CML: - - Increased Basophil count: i. Leading to release of histamine ii. Leading to itching, pruritis, flushing episodes, peptic ulcers, secretory diarrhea - Immature cell in P. Smear (Shift to left) - Infection: Neutrophil Alkaline phosphatase (NAP) score is lesser which is responsible for neutrophils to fight infections. - Normocytic Normochromic Anemia",
        "cop": 4,
        "opa": "Pruritus",
        "opb": "Infections",
        "opc": "Shift to left",
        "opd": "Autoimmune haemolytic anemia",
        "subject_name": "Medicine",
        "topic_name": "CLL & CML",
        "id": "c81ef453-22de-4df2-83d3-defb851a86ab",
        "choice_type": "single"
    },
    {
        "question": "Roth spots are seen in?",
        "exp": "Roth spots are white-centered retinal hemorrhages seen on fundoscopic examination. These are found in infective endocarditis, leukemia and lymphoma.",
        "cop": 1,
        "opa": "Leukemia",
        "opb": "Adreno-leukodystrophy",
        "opc": "Metachromatic leukodystrophy",
        "opd": "Gaucher disease",
        "subject_name": "Medicine",
        "topic_name": "CLL & CML",
        "id": "0bf31365-aad8-463c-9584-ab3b7b5f9146",
        "choice_type": "single"
    }
]